Comparison of standard dose with high dose of methylprednisolone in the management of COVID-19 patients admitted in ICU

CONTEXT: The pathological progression in severe Coronavirus Disease 2019 (COVID-19) includes an excessive and unregulated pro-inflammatory cytokine storm. Though the efficacy of corticosteroids like methylprednisolone (MPS) in severe COVID-19 is proven now, its dose and duration are not precise. AIM...

Descripción completa

Detalles Bibliográficos
Autores principales: Singhai, Abhishek, Bhagtana, Parneet Kaur, Pawar, Neeraj, Pavan, G. Sai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797098/
https://www.ncbi.nlm.nih.gov/pubmed/35136768
http://dx.doi.org/10.4103/jfmpc.jfmpc_908_21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797098/
https://www.ncbi.nlm.nih.gov/pubmed/35136768
http://dx.doi.org/10.4103/jfmpc.jfmpc_908_21

Ejemplares similares